Cooper Companies (COO) Income from Non-Controlling Interests (2012 - 2016)
Cooper Companies (COO) posted Income from Non-Controlling Interests of $300000.0 for Q3 2016, little changed on a QoQ basis from $300000.0 in Q2 2016, and up 2.74% year-over-year from $292000.0 in Q3 2015.
Powered by 
Analysis
Cooper Companies (COO) Income from Non-Controlling Interests (2012 - 2016) Analysis & Trends
Cooper Companies has reported Income from Non-Controlling Interests for 5 years, with the latest figure at $300000.0 in Q3 2016.
- On a quarterly basis, Income from Non-Controlling Interests rose 2.74% year-over-year to $300000.0 in Q3 2016; TTM through Apr 2017 was $300000.0, a 75.14% decrease from a year earlier, with the FY2018 full-year figure at $3.1 million, changed N/A from the prior year.
- Income from Non-Controlling Interests was $300000.0 for Q3 2016 at Cooper Companies, roughly flat from $300000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $605000.0 in Q3 2014, with the low at -$85000.0 in Q4 2013.
- Average Income from Non-Controlling Interests over 5 years is $325588.2, with a median of $300000.0 recorded in 2016.
- The sharpest annual moves came in 2013 and 2014: Income from Non-Controlling Interests plunged 137.61% in 2013, then surged 654.12% in 2014.
- Over 5 years, Income from Non-Controlling Interests stood at $226000.0 in 2012, then slumped by 137.61% to -$85000.0 in 2013, then soared by 654.12% to $471000.0 in 2014, then tumbled by 33.12% to $315000.0 in 2015, then declined by 4.76% to $300000.0 in 2016.
- The last three Income from Non-Controlling Interests figures came in at $300000.0 (Q3 2016), $300000.0 (Q2 2016), and $300000.0 (Q1 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 900,000.00 |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2016 | 300,000.00 |
| Apr 30, 2016 | 300,000.00 |
| Jan 31, 2016 | 300,000.00 |
| Oct 31, 2015 | 315,000.00 |
| Jul 31, 2015 | 292,000.00 |
| Apr 30, 2015 | 424,000.00 |
| Jan 31, 2015 | 570,000.00 |
| Oct 31, 2014 | 471,000.00 |
| Jul 31, 2014 | 605,000.00 |
| Apr 30, 2014 | 476,000.00 |
| Jan 31, 2014 | 422,000.00 |
| Oct 31, 2013 | -85,000.00 |
| Jul 31, 2013 | 241,000.00 |
| Apr 30, 2013 | 331,000.00 |
| Jan 31, 2013 | 268,000.00 |
| Oct 31, 2012 | 226,000.00 |
| Jul 31, 2012 | 79,000.00 |